Acute renal failure after cardiopulmonary bypass: a possible association with drugs of the fibrate group
- PMID: 10687672
- DOI: 10.1177/107424840000500105
Acute renal failure after cardiopulmonary bypass: a possible association with drugs of the fibrate group
Abstract
Background: Renal failure is a recognized, but infrequent, complication following cardiac surgery. The causes for this condition are multifactorial, and a major concern is that the occurrence of postoperative acute renal failure is still associated with a high mortality rate.
Methods and materials: We report unexpected acute renal failure occurring in 4 patients after uncomplicated cardiac surgery. Each patient was taking a fibric acid derivative at the time of surgery. Renal failure occurred rapidly within 3 days of surgery and was associated with increased concentrations of skeletal muscle-derived creatine kinase (CK). One patient developed myoglobinuria, and another developed a malignant hyperthermia-like syndrome.
Conclusions: These cases show that patients receiving lipid lowering medications could be at higher risk of developing acute renal failure after cardiac surgery. This association merits careful evaluation in large prospective studies and, if proved, would suggest that patients taking either statins or fibrates should discontinue doing so before cardiac surgery.
Similar articles
-
Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report.Eur J Clin Pharmacol. 2009 Dec;65(12):1169-74. doi: 10.1007/s00228-009-0723-7. Epub 2009 Sep 16. Eur J Clin Pharmacol. 2009. PMID: 19756555 Review.
-
The association between rhabdomyolysis and acute renal failure in patients undergoing cardiopulmonary bypass.J Cardiovasc Surg (Torino). 1996 Apr;37(2):153-9. J Cardiovasc Surg (Torino). 1996. PMID: 8675522
-
Rhabdomyolysis and acute renal failure following a switchover of therapy between two fibric acid derivatives.Singapore Med J. 2001 Aug;42(8):368-72. Singapore Med J. 2001. PMID: 11764054
-
Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?Nephrol Dial Transplant. 2000 Dec;15(12):1993-9. doi: 10.1093/ndt/15.12.1993. Nephrol Dial Transplant. 2000. PMID: 11096145
-
Perfusionist techniques of reducing acute kidney injury following cardiopulmonary bypass: an evidence-based review.Perfusion. 2015 Jan;30(1):25-32. doi: 10.1177/0267659114544395. Epub 2014 Jul 29. Perfusion. 2015. PMID: 25073949 Review.
Cited by
-
Cell-specific toxicity of fibrates in human embryonal rhabdomyosarcoma cells.Naunyn Schmiedebergs Arch Pharmacol. 2003 Mar;367(3):289-96. doi: 10.1007/s00210-002-0660-9. Epub 2003 Feb 8. Naunyn Schmiedebergs Arch Pharmacol. 2003. PMID: 12644902
-
Fenofibrate-induced hyperhomocysteinaemia: clinical implications and management.Drug Saf. 2003;26(2):81-91. doi: 10.2165/00002018-200326020-00002. Drug Saf. 2003. PMID: 12534325 Review.
-
Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report.Eur J Clin Pharmacol. 2009 Dec;65(12):1169-74. doi: 10.1007/s00228-009-0723-7. Epub 2009 Sep 16. Eur J Clin Pharmacol. 2009. PMID: 19756555 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials